Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
The Notch signaling pathway is a highly conserved cell communication mechanism found across organisms, from unicellular to complex multicellular life forms. It plays a crucial role in cell fate determination, differentiation, proliferation, apoptosis, and stem cell maintenance. The pathway primarily operates through direct contact between Notch receptors and ligands on adjacent cells, ensuring precise signal transmission and avoiding external interference. This direct contact mechanism allows for efficient and accurate intercellular communication.
The main components of the Notch signaling pathway include Notch receptors and their ligands. In mammals, there are four Notch receptors (Notch1 to Notch4), and their ligands belong to the Delta family (Delta-like1, Delta-like3, Delta-like4) and the Jagged/Serrate family (Jagged1, Jagged2). The interactions between these receptors and ligands are critical not only for embryonic development, cell differentiation, and tissue repair but also for maintaining tissue homeostasis and organ function.
Explore the intricacies of Notch signaling with Creative Biogene's advanced research tools. Trust our comprehensive solutions to support your research and drive your discoveries forward. Visit our website or contact us today to learn more.
| Cat.No. | Product Name | Price |
| CSC-SC007847 | Panoply™ Human JAG2 Over-expressing Stable Cell Line | Inquiry |
| CSC-DC007847 | Panoply™ Human JAG2 Knockdown Stable Cell Line | Inquiry |
| CLKO-2069 | JAG2 KO Cell Lysate-Hela | Inquiry |
| CSC-RT2425 | Human JAG2 Knockout Cell Line-Hela | Inquiry |
| CSC-SC010518 | Panoply™ Human NOTCH4 Over-expressing Stable Cell Line | Inquiry |
| CSC-DC010518 | Panoply™ Human NOTCH4 Knockdown Stable Cell Line | Inquiry |
| CSC-SC010517 | Panoply™ Human NOTCH3 Over-expressing Stable Cell Line | Inquiry |
| CSC-DC010517 | Panoply™ Human NOTCH3 Knockdown Stable Cell Line | Inquiry |
| CLKO-1312 | NOTCH3 KO Cell Lysate-HEK293T | Inquiry |
| CSC-RT1462 | Human NOTCH3 Knockout Cell Line-HEK293T | Inquiry |
Notch receptors are located on the cell membrane and bind to ligands via their extracellular domains. Ligands, such as members of the Jagged or Delta families, are present on the signaling cell's membrane. When two cells come into contact, the ligand binds to the Notch receptor, triggering a conformational change in the receptor. This interaction initiates a series of proteolytic cleavages, leading to downstream signal activation.
Activation of Notch receptors involves two critical proteolytic cleavages. The first cleavage is carried out by ADAM (a disintegrin and metalloprotease) metalloproteases on the extracellular domain of the receptor. This initial cleavage releases the extracellular portion of the Notch receptor, preparing it for the second cleavage. The second cleavage occurs in the membrane domain by the γ-secretase complex, releasing the Notch intracellular domain (NICD). NICD then enters the nucleus to further activate downstream signals.
Released NICD translocates to the nucleus and binds to the transcription factor CSL (also known as RBP-Jκ, CBF1, or Suppressor of Hairless). This binding converts CSL from a transcriptional repressor complex into an activator complex. The activated complex recruits co-activators such as Mastermind-like (MAML) proteins, leading to the transcription of target genes. Hes and Hey family genes are among these targets, playing key roles in cell fate determination and differentiation regulation.
The strength and duration of Notch signaling are tightly regulated to ensure precision. Regulatory mechanisms include ligand expression levels, receptor numbers, protease activity, and feedback regulation of downstream signals. For example, ligand expression levels directly affect receptor activation, while the activities of ADAM metalloproteases and γ-secretase determine the efficiency of Notch receptor cleavage.
Fringe proteins are important regulatory factors that modify Notch receptors, affecting their affinity for different ligands. Fringe modifies Notch receptors through glycosylation, altering their ligand-binding affinity and thereby changing the strength and duration of the signal. This regulatory mechanism ensures the flexibility and adaptability of signal transmission.
Dynamic balance in Notch signaling also depends on the degradation of NICD and ligands. After signal transmission, timely degradation of receptors and ligands is necessary to prevent sustained activation. This process includes the degradation of NICD and internalization of ligands, ensuring signal termination and system reset.
Figure 1. Overview of the NOTCH signaling pathway and therapeutic targets. (Zhou B, et al., 2022)
Under normal physiological conditions, Notch signaling is essential for embryonic development, vascular formation, immune system establishment, and neural development. For instance, during embryonic development, Notch signaling determines cell fate and differentiation, playing a fundamental role in tissue and organ development. In vascular formation, Notch signaling regulates endothelial cell proliferation and differentiation, ensuring proper blood vessel formation and function. In the immune system, Notch signaling is involved in T cell development and function, critically impacting immune system operations.
Aberrant Notch signaling is associated with various diseases. In cancer, abnormal activation or inhibition of Notch signaling can lead to uncontrolled cell proliferation and tumor formation. For example, mutations in Notch1 in T-cell acute lymphoblastic leukemia (ALL) cause its overactivation, driving leukemia cell proliferation and survival. In breast cancer, abnormal Notch signaling is linked to increased invasiveness and metastasis of cancer cells.
Notch signaling is also related to cardiovascular diseases, neurodegenerative disorders, and developmental abnormalities beyond cancer. For example, in cardiovascular diseases, aberrant Notch signaling may lead to abnormal blood vessel development and atherosclerosis. In neurodegenerative diseases like Alzheimer's, dysregulated Notch signaling can contribute to neuronal death and memory loss. Developmental disorders such as Alagille syndrome and Spondylocostal Dysostosis are associated with Notch signaling abnormalities.
Given its critical role in various diseases, Notch signaling has become an important target for drug development and therapeutic strategies. Researchers are exploring new treatment approaches by designing inhibitors targeting Notch receptors, ligands, γ-secretase, or downstream transcription factors. For instance, γ-secretase inhibitors are being used to treat certain cancers. Precise modulation of Notch signaling holds promise for providing new therapeutic options for cancer, cardiovascular diseases, neurodegenerative disorders, and more.
The Notch signaling pathway plays a key role in cell fate determination, developmental regulation, and disease progression. Its complex signaling and regulatory mechanisms are crucial in both physiological and pathological processes. Understanding the functions and regulation of Notch signaling helps reveal disease mechanisms and offers new insights and strategies for clinical treatment. Future research will further expand our understanding of Notch signaling's role in health and disease, driving the development of novel therapeutic methods.
Reference:
Copyright © Creative Biogene. All rights reserved.